NEW YORK (GenomeWeb News) – Shanghai-based biotech firm WuXi AppTec said today that it will partner with Qiagen to develop an integrated biomarker service, as well as new biomarkers and assays.

Under the agreement, Qiagen will provide tools, training, and consumables, while WuXi will contribute its Shanghai lab facilities and staff to conduct the biomarker services. The lab is scheduled to begin operating immediately.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Sponsored by

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Sponsored by

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.